Key facts
- VieCure’s last known valuation is $90.0M (Mar 2021).
- It has raised $113.0M; the latest was Later Stage VC ($43.0M) in Nov 2025.
- Notable investors include Socium Ventures, Durable Capital Partners, Sator Grove Holdings, Mitchell Rales, Northpond Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for VieCure
- ·The full record, as it builds
Funding rounds
No funding rounds for VieCure are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About VieCure
Operator of a comprehensive cancer care AI platform intended to empower people to live healthy lives. The company's platform utilizes artificial intelligence that helps generate patient-specific treatment plans in real-time for oncologists and patients, enabling healthcare professionals with clinical quality care and to help patients embrace life.
- Sector
- Healthcare
- HQ
- Greenwood Village, CO, United States
- Founded
- 2015
- Employees
- 97
- Website
- viecure.com/
- Ownership
- Privately Held (backing)
VieCure doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in VieCure shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on VieCure in its N-PORT filings yet. We sweep new filings monthly.